Krones

Krones AG is the world's largest manufacturer of beverage-filling and packaging lines — the machines that fill, label, cap, and palletize every PET-bottled water, soft drink, beer, and dairy product on the planet. Customers include Coca-Cola, PepsiCo, AB InBev, Heineken, Carlsberg, Nestle Waters, Danone, and most of the regional Big-3 bottlers in every continent. Founded 1951 in Neutraubling near Regensburg, Bavarian Mittelstand to the core, family-controlled through the Kronseder family which still holds approximately 51 percent of the share capital.

At 116.80 EUR, the stock sits at the 20.9th percentile of its 52-week range (low 109.20, high 145.60), well below the 50-day moving average of 121.93 and the 200-day at 128.96. Revenue 5.69 billion EUR FY2025 (minus 2.5 percent year-over-year), trailing P/E 12.7, forward P/E 10.0, EV/EBITDA 6.7. Debt-to-equity of just 2.15 percent — essentially net cash. Dividend yield 2.4 percent at a 28 percent payout ratio. By every traditional valuation metric this is a cheap-to-fairly-cheap European industrial.

The drawdown is cyclical, not structural. 2024 to 2025 beverage capex compressed sharply — Coca-Cola FY2024 capex declined 18 percent, PepsiCo declined 12 percent. After 2020-to-2023 over-investment in PET filling lines (post-pandemic ramp), the bottlers paused. Krones operating margin compressed to 4.2 percent (versus peak 8.2 percent in 2018), and the market re-rated the stock from 18x earnings to 12x.

Analyst consensus 155.11 EUR (9 names, Buy rating, undervalued signal) — 32.8 percent upside. The setup is textbook deep-cyclical European industrial: cycle bottom, near-net-cash balance sheet, family-controlled patient capital, secular EU-recycling mandate tailwind, and a customer base that physically must replace filling lines every 7 to 10 years regardless of cycle timing.

The Kronseder family (founder descendants) holds approximately 51 percent through the Krones Holding family vehicle — this is a Bavarian Mittelstand family compounder, not a financial-investor-controlled position. The remaining 49 percent free-float is dominated by European institutional investors: Allianz Global Investors (5.8 percent), Union Investment (4.2 percent), DWS Group (3.6 percent), Norges Bank (2.9 percent). UK and US institutional ownership is unusually thin for a stock of this size — international fund managers tend to underweight Mittelstand family-controlled mid-caps, which is part of why the multiple lags peers.

Short interest is reported at zero — there is no active short thesis. Smart-money buying has been concentrated in dividend-and-quality factor funds since the 200-day-MA breakdown in Q3 2025; volume profile shows accumulation at the 110 to 115 EUR price level. The Kronseder family has held since IPO 1984 and has not sold any disclosed shares since 2019 — multi-decade hold pattern. A strategic-acquirer scenario (Tetra Pak parent group Tetra Laval, or Italian rival Sidel-Sacmi) would require family approval, which has not been forthcoming despite occasional press speculation in 2020 and 2023.

At 116.80 EUR Krones trades on 12.7x trailing P/E, 10.0x forward P/E, 0.65x sales, 1.67x book, 6.7x EV/EBITDA, and yields 2.4 percent. Every metric except gross margin (52.8 percent — healthy) screams cycle bottom. Free cash flow of 28.8 million EUR in 2025 is well below the 200 to 250 million EUR mid-cycle range — operating leverage to recovery is large.

Three valuation paths. (1) Multiple-only re-rating to historical 14x forward P/E without earnings improvement — 145 EUR per share, 24 percent upside; (2) Operating-margin recovery to 6.5 percent on flat revenue at current 12x P/E — 160 EUR per share, 37 percent upside; (3) Both multiple expansion to 14x and margin recovery to 7 percent on 3 to 5 percent revenue growth — 185 to 195 EUR per share, 58 to 67 percent upside. Analyst consensus 155 EUR aligns with the middle path. The high-end analyst target of 189 EUR aligns with full cycle-recovery scenario.

1. Q1 2026 results (early May 2026):

   Operating margin trajectory and the orderbook-to-revenue ratio. A 6 to 12 percent year-over-year orderbook growth on flat revenue would signal the inflection. Consensus expects 70 million EUR Q1 operating profit; a clean print above 80 million is the bull-thesis trigger.

2. EU SUP-Directive interim review (H2 2026):

   The European Commission interim review of progress toward the 30 percent recycled content target. If member states fall behind (which is likely — current PET-recycling capacity is approximately 18 percent), the Commission proposes enforcement actions, accelerating bottler capex.

3. Capital Markets Day H2 2026:

   Management has hinted at a refreshed medium-term margin and growth framework. Formal articulation of an 8 percent-plus 2028 operating margin target would trigger meaningful institutional buying.

Krones is the kind of cycle-bottom European industrial that quantitative value strategies and patient German Mittelstand specialists buy and hold for 24 to 36 months. The multi-decade family control gives you patient capital — the family does not optimize for quarterly results. The structural EU recycling tailwind gives you a regulatory catalyst that does not depend on cycle timing. The 20.9th-percentile entry is the kind of mean-reversion setup that screens green on every value factor model.

The risk is timing — the operating-margin recovery is structurally plausible but the trigger event is hard to date. I would size at 2 to 3 percent of portfolio with a 24 to 36 month horizon and a 100 EUR stop-loss (8 percent below the 52-week low). Upside scenarios cluster at 155 to 185 EUR; downside at 95 to 105. Asymmetry roughly 3-to-1 favorable. A good-quality patient-capital long in a portfolio sleeve for European industrials. This is a hold-and-collect-2.4-percent-yield-while-waiting trade.